Adenosine

solute carrier family 29 member 1 (Augustine blood group) ; Homo sapiens







67 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35042768 Dopamine Release in Nucleus Accumbens Is under Tonic Inhibition by Adenosine A1 Receptors Regulated by Astrocytic ENT1 and Dysregulated by Ethanol. 2022 Mar 2 10
2 35408815 Repurposing Dipyridamole in Niemann Pick Type C Disease: A Proof of Concept Study. 2022 Mar 22 2
3 33052430 Adaptative mechanism of the equilibrative nucleoside transporter 1 (ENT-1) and blood adenosine levels in elite freedivers. 2021 Jan 3
4 34283374 A review of the effects of ticagrelor on adenosine concentration and its clinical significance. 2021 Dec 3
5 31721163 β3 Adrenoceptor-induced cholinergic inhibition in human and rat urinary bladders involves the exchange protein directly activated by cyclic AMP 1 favoring adenosine release. 2020 Apr 1
6 32066489 Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial. 2020 Feb 17 4
7 32126230 HPLC reveals novel features of nucleoside and nucleobase homeostasis, nucleoside metabolism and nucleoside transport. 2020 Jul 1 2
8 32141895 Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia. 2020 May 2
9 32523687 Sustained adenosine exposure causes endothelial mitochondrial dysfunction via equilibrative nucleoside transporters. 2020 Apr-Jun 5
10 32824670 Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells. 2020 Aug 18 3
11 32858046 Intracellular adenosine released from THP-1 differentiated human macrophages is involved in an autocrine control of Leishmania parasitic burden, mediated by adenosine A2A and A2B receptors. 2020 Oct 15 4
12 33324223 Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities. 2020 3
13 29851527 Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study. 2019 2
14 31235912 Structures of human ENT1 in complex with adenosine reuptake inhibitors. 2019 Jul 5
15 31551431 Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1. 2019 Sep 24 1
16 29483661 Cell-subtype-specific changes in adenosine pathways in schizophrenia. 2018 Jul 1
17 29680437 Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis. 2018 May 1
18 29871907 Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). 2018 Oct 1 3
19 27995448 Functional characterization of human equilibrative nucleoside transporter 1. 2017 Apr 3
20 28041785 A semi-quantitative translational pharmacology analysis to understand the relationship between in vitro ENT1 inhibition and the clinical incidence of dyspnoea and bronchospasm. 2017 Feb 15 3
21 28292464 Intracellular acidification increases adenosine transport in human umbilical vein endothelial cells. 2017 Mar 2
22 27694321 Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor. 2016 Dec 8 1
23 25351985 Insulin requires normal expression and signaling of insulin receptor A to reverse gestational diabetes-reduced adenosine transport in human umbilical vein endothelium. 2015 Jan 3
24 25725289 Adenosine A1 receptor activation modulates human equilibrative nucleoside transporter 1 (hENT1) activity via PKC-mediated phosphorylation of serine-281. 2015 May 3
25 25869606 Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. 2015 Aug 2
26 26070128 Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury? 2015 Jun 2
27 26156883 Effect of P2Y12 inhibitors on inflammation and immunity. 2015 Aug 31 1
28 24163005 The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity. 2014 3
29 24586402 Aberrant bone density in aging mice lacking the adenosine transporter ENT1. 2014 1
30 24768873 Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance. 2014 Jun 17 1
31 24119573 Role of equilibrative adenosine transporters and adenosine receptors as modulators of the human placental endothelium in gestational diabetes mellitus. 2013 Dec 1
32 24122028 Intracellular adenosine inhibits IgE-dependent degranulation of human skin mast cells. 2013 Nov 2
33 21266914 Physiological and pharmacological roles of vascular nucleoside transporters. 2012 Jan 4
34 21678404 New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal transition in renal tubular cells. 2012 Apr 1
35 22409811 Intracortical injection of endothelin-1 induces cortical infarcts in mice: effect of neuronal expression of an adenosine transporter. 2012 Mar 12 2
36 21223299 Implication of the purinergic system in alcohol use disorders. 2011 Apr 2
37 21283641 Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. 2011 Jan 24 4
38 21395582 Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions. 2011 Jul 1
39 21453390 Neuronal ENT1 takes up synaptic adenosine even under hypoxia/ischemia. 2011 Jul 1
40 21515851 Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. 2011 Jun 1
41 20113503 Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter. 2010 Jan 29 1
42 20728214 Differential expression of functional nucleoside transporters in non-differentiated and differentiated human endothelial progenitor cells. 2010 Oct 3
43 20814156 Human erythrocyte nucleoside transporter ENT1 functions at ice-cold temperatures. 2010 1
44 21054262 An essential role for adenosine signaling in alcohol abuse. 2010 Sep 1
45 19193655 TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium. 2009 Jun 1 3
46 19222701 Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons. 2009 Apr 1
47 18064606 High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium. 2008 Jun 6
48 18703227 Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. 2008 Sep 2
49 17167068 A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release. 2007 Feb 1
50 17883419 Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients. 2007 Nov 1